|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:levothyroxine_sodium
|
|
gptkbp:approvedBy
|
1955
|
|
gptkbp:ATCCode
|
H03AA01
|
|
gptkbp:bioavailability
|
40-80%
|
|
gptkbp:brand
|
gptkb:levothyroxine
|
|
gptkbp:color
|
varies by strength
|
|
gptkbp:contraindication
|
gptkb:thyrotoxicosis
gptkb:acute_myocardial_infarction
|
|
gptkbp:drugClass
|
hormone
|
|
gptkbp:FDAApproved
|
yes
|
|
gptkbp:form
|
gptkb:tablet
oral tablet
100 mcg
50 mcg
112 mcg
125 mcg
137 mcg
150 mcg
175 mcg
200 mcg
25 mcg
300 mcg
75 mcg
88 mcg
|
|
gptkbp:genericName
|
gptkb:levothyroxine
|
|
gptkbp:halfLife
|
about 7 days
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Synthroid
|
|
gptkbp:interactsWith
|
gptkb:warfarin
gptkb:cholestyramine
iron supplements
calcium supplements
antacids
|
|
gptkbp:legalStatus
|
Rx-only (US)
|
|
gptkbp:manufacturer
|
gptkb:AbbVie
|
|
gptkbp:marketedIn
|
gptkb:Australia
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:pregnancyCategory
|
A (US)
|
|
gptkbp:prescribes
|
gptkb:cancer
gptkb:Hashimoto's_thyroiditis
goiter
congenital hypothyroidism
myxedema coma
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
anxiety
weight loss
sweating
insomnia
palpitations
increased appetite
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:usedFor
|
hypothyroidism
thyroid hormone replacement
|
|
gptkbp:bfsParent
|
gptkb:levothyroxine_sodium
gptkb:L-thyroxine
gptkb:levothyroxine
|
|
gptkbp:bfsLayer
|
7
|